ERBB2 and gastric cancer: Besides, among patients with HER2 amplification, those who also exhibit IKZF3 amplification have a worse prognosis (Fig. 4E-F), highlighting the clinical significance of IKZF3 amplification in stratifying HER2-amplified GC patients.